Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,888,995
  • Shares Outstanding, K 701,980
  • Annual Sales, $ 0 K
  • Annual Income, $ -614,930 K
  • EBIT $ -159 M
  • EBITDA $ -157 M
  • 60-Month Beta -0.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 80.11

Options Overview Details

View History
  • Implied Volatility 122.82% ( +3.01%)
  • Historical Volatility 128.00%
  • IV Percentile 51%
  • IV Rank 13.82%
  • IV High 631.33% on 10/26/23
  • IV Low 41.28% on 11/07/23
  • Put/Call Vol Ratio 0.34
  • Today's Volume 3,229
  • Volume Avg (30-Day) 8,334
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 72,498
  • Open Int (30-Day) 105,136

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.12 +13.13%
on 10/04/24
25.50 -19.61%
on 09/23/24
-3.89 (-15.95%)
since 09/20/24
3-Month
8.80 +132.95%
on 07/22/24
33.89 -39.51%
on 09/16/24
+11.72 (+133.35%)
since 07/19/24
52-Week
1.64 +1,150.00%
on 11/09/23
33.89 -39.51%
on 09/16/24
+18.65 (+1,008.11%)
since 10/20/23

Most Recent Stories

More News
Up 700% This Year, Is It Too Late to Invest in This Stock?

The shares have experienced a pullback in the past couple of weeks.

SMMT : 20.50 (-3.35%)
MRK : 106.34 (-2.17%)
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

It's hard to go wrong with either company, but one is more appealing.

VKTX : 64.34 (-2.22%)
MS : 118.28 (-2.30%)
SMMT : 20.50 (-3.35%)
LLY : 906.13 (-1.29%)
3 Things You Need to Know If You Buy Summit Therapeutics Stock Today

It's easier to invest confidently when you know both the pros and the cons in full.

SMMT : 20.50 (-3.35%)
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts

The investment bank analysts who follow these stocks think they can soar even further, with some caveats.

VKTX : 64.34 (-2.22%)
SMMT : 20.50 (-3.35%)
MRK : 106.34 (-2.17%)
Is Summit Therapeutics a Millionaire Maker?

This company's promising cancer drug could challenge Merck's $25 billion crown jewel.

SMMT : 20.50 (-3.35%)
Stocks Rally as a Strong US Jobs Report Bolsters Soft-Landing Prospects

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.71%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.19%. Stocks rallied today as...

AMAT : 184.46 (-1.02%)
CVS : 58.17 (-2.52%)
AZEK : 43.20 (-2.11%)
DHI : 186.27 (-4.26%)
VZ : 43.70 (-0.66%)
ADI : 225.67 (-1.16%)
RIVN : 10.03 (-0.10%)
TXN : 195.77 (-1.36%)
$IUXX : 20,361.47 (+0.18%)
ZNZ24 : 111-100 (-0.18%)
LNW : 91.68 (-1.77%)
PHM : 144.26 (-3.21%)
Could Summit Therapeutics Become the Next Merck?

Recent developments are forcing comparisons between these two drugmakers.

SMMT : 20.50 (-3.35%)
MRK : 106.34 (-2.17%)
Where Will Summit Therapeutics Be in 3 Years?

There's a lot riding on how its collaborator's studies end up performing.

SMMT : 20.50 (-3.35%)
Has Summit Therapeutics Stock Already Peaked?

Summit Therapeutics stock is up a remarkable 700% this year.

SMMT : 20.50 (-3.35%)
Is Summit Therapeutics Stock a Buy?

Its alliance with a successful foreign biotech could be decisive for the stock.

AZN : 77.44 (-1.05%)
SMMT : 20.50 (-3.35%)
PFE : 28.93 (-0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 23.42
2nd Resistance Point 22.81
1st Resistance Point 21.65
Last Price 20.50
1st Support Level 19.88
2nd Support Level 19.27
3rd Support Level 18.11

See More

52-Week High 33.89
Fibonacci 61.8% 21.57
Last Price 20.50
Fibonacci 50% 17.76
Fibonacci 38.2% 13.96
52-Week Low 1.64

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar